DC Court Hears Rescheduling Appeal
ASA Submits Brief on Patients’ Right to Sue in Landmark Federal Case. Learn more about Americans for Safe Access.[message type=”custom” width=”100%” color=”#CCCCCC” border=”#C9C9C9″ color=”#333333″]The landmark case is an appeal of the DEA’s decision last year to deny the 2002 rescheduling petition by the Coalition for Rescheduling Cannabis, of which ASA is a member. It marks the first time in nearly 20 years that a federal court has heard arguments on the classification of cannabis as a Schedule I substance, a category reserved for drugs with a high potential for abuse and no current accepted medical use that cannot be used safely even under medical supervision.
A decision from the court on whether the case can proceed is expected within the next several months.
“The current classification of cannabis is based more on politics than science,” said Elford. “This is an historic opportunity for patients and doctors to confront politically motivated decision-making with the scientific evidence that cannabis is a safe, effective medicine that can meet the needs of millions of patients.”
Read more about the ASA rescheduling appeal brief. [/message]